Description | Human GPNMB knockout Hs578T cell line is edited by our special CRISPR/Cas9 technology. Hs578T are epithelial cells isolated from breast tissue from a 74-year-old Caucasian female breast cancer patient. These cells are used in breast cancer research. |
Size | 1 vial (2*106 cells/vial) |
Parental Cell Line | Hs578T |
Biosafety Level | 1 |
Fromat | Frozen |
Culture Conditions | Cells are adherent cells that are cultured at 37°C in a humidified atmosphere with 5% CO2. |
Subculture Guidelines | All seeding densities should be based on cell counts obtained by established methods. The recommended seeding density is 2*104 cells/cm2. If necessary, a partial replacement of the medium 24 hours before subculture may help promote growth. When the cells achieve 80-90% confluence, they should be passaged. |
Knockout Validation | Sanger Sequencing |
Viability | >95% viability before freezing. |
Adherent /Suspension | Adherent |
Disease | Carcinoma |
Purity | Immunogen affinity purified |
Storage | Vapor phase of liquid nitrogen |
Sterility | Mycoplasma negative, HOECHST and PCR |
Applications | For research use only |
Shipping Info | Dry Ice |
Species | Human |
Tested Applications | Suitable for: ICC, WB, Sanger Sequencing |
Tissue | Breast; Mammary gland |
Recommended Control | Human wild-type Hs578T cell line |
Doubling Time | Ca. 48 hours |
Morphology | Epithelial cell |
Karyotype | It is a hypotriploid human cell line |
Pathogens | HIV: Negative Hepatitis B: Negative Hepatitis C: Negative |
Product Type | Knockout Stable Cell Line |
Price | Inquiry |